## **Core Concept**
The broad beta disease, also known as **Broad-β disease** or **Fish oil disease**, is associated with a defect in the metabolism of very-long-chain fatty acids. This condition is linked to an enzyme deficiency involved in the breakdown of these fatty acids.

## **Why the Correct Answer is Right**
The correct answer, **C. VLCAD (Very-Long-Chain Acyl-CoA Dehydrogenase)**, is right because VLCAD is an enzyme crucial for the mitochondrial beta-oxidation of very-long-chain fatty acids. A deficiency in VLCAD leads to the accumulation of these fatty acids, causing a range of clinical symptoms including hypoglycemia, hepatomegaly, and cardiomyopathy. This condition is a type of **fatty acid oxidation disorder**.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify a known enzyme related to fatty acid metabolism disorders directly linked to broad beta disease.
- **Option B:** This option is incorrect as it does not directly relate to the specific enzymatic deficiency causing broad beta disease.
- **Option D:** This option is incorrect because it does not accurately represent the enzyme deficiency associated with broad beta disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **very-long-chain fatty acid dehydrogenase (VLCAD) deficiency** presents with episodes of **hypoglycemia**, **hepatomegaly**, and can lead to **cardiac dysfunction**. Early diagnosis through newborn screening and dietary management can significantly improve outcomes.

## **Correct Answer:** C. VLCAD (Very-Long-Chain Acyl-CoA Dehydrogenase).